Hung-Wei Kan

Hung-Wei Kan

Auto-generated profile, based on publicly available information

Hung-Wei Kan

School of Medicine for International Students, College of Medicine, I-Shou University, Kaohsiung 82445, Taiwan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
MLMing Tatt Lee
Ming Tatt Lee
WPWei-Hao Peng
Wei-Hao Peng
HKHung-Wei Kan
Hung-Wei Kan
CWChengchun Wu
Chengchun Wu
DWDeng-Wu Wang
Deng-Wu Wang
YHYu-Cheng Ho
Yu-Cheng Ho
Major depressive disorder (MDD) is a common neuropsychiatric disorder affecting the mood and mental well-being. Its pathophysiology remains elusive due to the complexity and heterogeneity of this disorder that affects millions of individuals worldwide. Chronic stress is frequently cited as the one of the risk factors for MDD. To date, the conventional monoaminergic theory (serotonin, norepinephrine, and/or dopamine dysregulation) has received the most attention in the treatment of MDD, and all available classes of antidepressants target these monoaminergic systems. However, the contributions of other neurotransmitter systems in MDD have been widely reported. Emerging preclinical and clinical findings reveal that maladaptive glutamatergic neurotransmission might underlie the pathophysiology of MDD, thus revealing its critical role in the neurobiology of MDD and as the therapeutic target. Aiming beyond the monoaminergic hypothesis, studies of the neurobiological mechanisms underlying the stress-induced impairment of AMPA (a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid)-glutamatergic neurotransmission in the brain could provide novel insights for the development of a new generation of antidepressants without the detrimental side effects. Here, the authors reviewed the recent literature focusing on the role of AMPA-glutamatergic neurotransmission in stress-induced maladaptive responses in emotional and mood-associated brain regions, including the hippocampus, amygdala, prefrontal cortex, nucleus accumbens and periaqueductal gray.

1 January 2018 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
HKHung-Wei Kan
Hung-Wei Kan
JHJung-Hsien Hsieh
Jung-Hsien Hsieh
HCHsiung-Fei Chien
Hsiung-Fei Chien
YLYea-Huey Lin
Yea-Huey Lin
TYTi-Yen Yeh
Ti-Yen Yeh
SHSung-Tsang Hsieh
Sung-Tsang Hsieh
To understand the pathology and molecular signatures of microangiopathy in diabetic neuropathy, we systemically and quantitatively examined the morphometry of microvascular and nerve pathologies of sural nerves. In the endoneurium of diabetic nerves, prominent microangiopathy evidenced by reduced capillary luminal area, increased capillary basement membrane thickness, and increased proportion of fibrin(+) blood vessels. Furthermore, capillary basement membrane thickness and the proportion of fibrin(+) blood vessels were correlated with small myelinated fiber density in diabetic nerves. In diabetic nerves, there was significant macrophage and T cell infiltration, and cluster of differentiation 40 (CD40) expression was increased. For molecular alterations in diabetic nerves, hypoxia-inducible factor-1α (HIF-1α), mitogen-activated protein kinase-activated protein kinase 2 (MK2), and phosphatase and tensin homolog (PTEN) were upregulated. In addition, HIF-1α was correlated with small myelinated fiber density and capillary luminal area, while both MK2 and PTEN were correlated with capillary basement membrane thickness in diabetic nerves. The molecular cascades were further demonstrated and replicated in a cell model of microangiopathy on human umbilical vein endothelial cells (HUVECs) exposed to high-glucose medium by silencing of CD40, PTEN and HIF-1α in HUVECs using shRNA. These data clarified the hierarchy of the molecular cascades, i.e., upregulation of CD40 leading to HIF-1α expression in endothelium and nerve fibers. In conclusion, this study demonstrated (1) the association of microangiopathy, thrombosis, and inflammatory infiltrates with nerve degeneration in diabetic nerves and (2) CD40 as a key molecule for the upregulation of HIF-1α and PTEN underlying the severity of microangiopathy.

10 January 2022 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
WPWei-Hao Peng
Wei-Hao Peng
HKHung-Wei Kan
Hung-Wei Kan
YHYu-Cheng Ho
Yu-Cheng Ho

8 February 2018 in Neuropathology and Applied Neurobiology
Verified
Journal Article
Closed access
PDF file
HKH.‐W. Kan
H.‐W. Kan
HCH. Chiang
H. Chiang
WLW.‐M. Lin
W.‐M. Lin
IYI.‐S. Yu
I.‐S. Yu
SLShu-Wha Lin
Shu-Wha Lin
SHSung-Tsang Hsieh
Sung-Tsang Hsieh

1 January 2019 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
YCYing-Shuang Chang
Ying-Shuang Chang
HKHung-Wei Kan
Hung-Wei Kan
YHYu-Lin Hsieh
Yu-Lin Hsieh
Background: Skin denervation that develops in patients with diabetes mellitus as a neuropathic manifestation is known as diabetic peripheral neuropathy (DPN). Skin denervation is parallel to neuronal injuries that alter intracellular signaling. To date, the correlation between nerve injury and the activation of intracellular responses to neuropathic manifestations has not been elucidated; specifically, whether activating transcription factor 3 (ATF3) is responsible for neuronal injury and a critical molecule that modulates the activation of intracellular protein kinase C epsilon (p-PKCε) and pain development in DPN is a crucial question. Methods: To address, ATF3 knockout (atf3−/− group, C57/B6 genetic background) and wild-type mice (atf3+/+ group) received a single dose of streptozotocin (200 mg/kg) to generate a mouse model of DPN. Results: Both atf3+/+ and atf3−/− mice exhibited hyperglycemia and the same pathology of skin denervation at posttreatment month 2, but only atf3+/+ mice developed thermal hyperalgesia (P<0.001) and mechanical allodynia (P=0.002). The atf3+/+ group, but not the atf3−/− group, had preferential ATF3 upregulation on p-PKCε(+) neurons with a ratio of 37.7%±6.1% in p-PKCε(+):ATF3(+) neurons (P<0.001). In addition, B-cell lymphoma-extra large (Bcl-XL), an antiapoptotic Bcl2 family protein, exhibited parallel patterns to p-PKCε (ie, Bcl-XL upregulation was reversed in atf3−/− mice). These two molecules were colocalized and increased by approximately two-fold in the atf3+/+ group compared with the atf3−/− group (30.0%±3.4% vs 13.7% ± 6.2%, P=0.003). Furthermore, linear analysis results showed that the densities of p-PKCε and Bcl-XL had a reverse linear relationship with the degrees of thermal hyperalgesia and mechanical allodynia. Conclusion: Collectively, this report suggested that ATF3 is a critical upstream molecule that modulates p-PKCε and Bcl-XL expression, which consequently mediated the development of neuropathic manifestation in DPN.

Verified
Journal Article
Open access
PDF file
HKHung-Wei Kan
Hung-Wei Kan
YHYu-Cheng Ho
Yu-Cheng Ho
YCYing-Shuang Chang
Ying-Shuang Chang
YHYu-Lin Hsieh
Yu-Lin Hsieh
Despite the worldwide prevalence and severe complications of type 2 diabetes mellitus (T2DM), the pathophysiological mechanisms underlying the development of diabetic polyneuropathy (DPN) are poorly understood. Beyond strict control of glucose levels, clinical trials for reversing DPN have largely failed. Therefore, understanding the pathophysiological and molecular mechanisms underlying DPN is crucial. Accordingly, this study explored biochemical and neuropathological deficits in a rat model of T2DM induced through high-fat diet (HFD) feeding along with two low-dose streptozotocin (STZ) injections; the deficits were explored through serum lipid, neurobehavioral, neurophysiology, neuropathology, and immunohistochemistry examinations. Our HFD/STZ protocol induced (1) mechanical hyperalgesia and depression-like behaviors, (2) loss of intraepidermal nerve fibers (IENFs) and reduced axonal diameters in sural nerves, and (3) decreased compound muscle action potential. In addition to hyperglycemia, which was correlated with the degree of mechanical hyperalgesia and loss of IENFs, we observed that hypertriglyceridemia was the most dominant deficit in the lipid profiles of the diabetic rats. In particular, SEPT9, the fourth component of the cytoskeleton, increased in the satellite glial cells (SGCs) of the dorsal root ganglia (DRG) in the T2DM-like rats. The number of SEPT9(+) SGCs/DRG was correlated with serum glucose levels and mechanical thresholds. Our findings indicate the putative molecular mechanism underlying DPN, which presumably involves the interaction of SGCs and DRG neurons; nevertheless, further functional research is warranted to clarify the role of SEPT9 in DPN.